Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP638935.RAbDqLTQUp9h-CO4W4sQRtRGnzKOQo_8IctscAaQS-Nv0130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP638935.RAbDqLTQUp9h-CO4W4sQRtRGnzKOQo_8IctscAaQS-Nv0130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP638935.RAbDqLTQUp9h-CO4W4sQRtRGnzKOQo_8IctscAaQS-Nv0130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP638935.RAbDqLTQUp9h-CO4W4sQRtRGnzKOQo_8IctscAaQS-Nv0130_provenance.
- NP638935.RAbDqLTQUp9h-CO4W4sQRtRGnzKOQo_8IctscAaQS-Nv0130_assertion description "[PP2A activator FTY720 has been shown to possess the anti-leukemic activity for chronic myelogenous leukemia (CML), however, the cell killing mechanism underlying its anti-leukemic activity has remained to be verified.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP638935.RAbDqLTQUp9h-CO4W4sQRtRGnzKOQo_8IctscAaQS-Nv0130_provenance.
- NP638935.RAbDqLTQUp9h-CO4W4sQRtRGnzKOQo_8IctscAaQS-Nv0130_assertion evidence source_evidence_literature NP638935.RAbDqLTQUp9h-CO4W4sQRtRGnzKOQo_8IctscAaQS-Nv0130_provenance.
- NP638935.RAbDqLTQUp9h-CO4W4sQRtRGnzKOQo_8IctscAaQS-Nv0130_assertion SIO_000772 23851982 NP638935.RAbDqLTQUp9h-CO4W4sQRtRGnzKOQo_8IctscAaQS-Nv0130_provenance.
- NP638935.RAbDqLTQUp9h-CO4W4sQRtRGnzKOQo_8IctscAaQS-Nv0130_assertion wasDerivedFrom befree-20150227 NP638935.RAbDqLTQUp9h-CO4W4sQRtRGnzKOQo_8IctscAaQS-Nv0130_provenance.
- NP638935.RAbDqLTQUp9h-CO4W4sQRtRGnzKOQo_8IctscAaQS-Nv0130_assertion wasGeneratedBy ECO_0000203 NP638935.RAbDqLTQUp9h-CO4W4sQRtRGnzKOQo_8IctscAaQS-Nv0130_provenance.
- befree-20150227 importedOn "2015-02-27" NP638935.RAbDqLTQUp9h-CO4W4sQRtRGnzKOQo_8IctscAaQS-Nv0130_provenance.